Phytomedicine · 2026 Huangjin Shuangshen Jiawei decoction alleviated coronary heart disease comorbid with depression partly through gut microbiota-mediated regulation of the SRSF1-p53-ASPP1 signaling axis. Jia R, Wang Y, Wang J, et al. Faecalibacterium prausnitzii PubMed ↗
BMC medicine · 2026 Circulating imidazole propionate and coronary heart disease risk: interplay between histidine intake, fiber, and gut microbiome. Liang X, Zhu L, Li J, et al. Blautia PubMed ↗
Journal of cardiovascular pharmacology · 2026 Role of the Gut Microbiome in Modulating Interactions Between β-Lactam Antibiotics and Statins in Coronary Heart Disease. Wang G, Luo Y, Song S, et al. Faecalibacterium PubMed ↗
Nutrients · 2024 Lactiplantibacillus plantarum P470 Isolated from Fermented Chinese Chives Has the Potential to Improve In Vitro the Intestinal Microbiota and Biological Activity in Feces of Coronary Heart Disease (CHD) Patients. Yang L, Wu Y, Yang J, et al. Lactiplantibacillus plantarumBacteroides PubMed ↗
Probiotics and antimicrobial proteins · 2024 An In Vitro Evaluation of the Effect of Bifidobacterium longum L556 on Microbiota Composition and Metabolic Properties in Patients with Coronary Heart Disease (CHD). Yang L, Wu Y, Zhao X, et al. Bifidobacterium longumFaecalibacterium PubMed ↗
Frontiers in cellular and infection microbiology · 2022 Regional pattern and signatures of gut microbiota in rural residents with coronary heart disease: A metagenomic analysis. Li W, Li H, Wang S, et al. Agathobacter rectalis PubMed ↗
Randomized trial Probiotics and antimicrobial proteins · 2019 The Effects of Synbiotic Supplementation on Carotid Intima-Media Thickness, Biomarkers of Inflammation, and Oxidative Stress in People with Overweight, Diabetes, and Coronary Heart Disease: a Randomized, Double-Blind, Placebo-Controlled Trial. Farrokhian A, Raygan F, Soltani A, et al. Bifidobacterium bifidumLactobacillus acidophilus PubMed ↗
Frontiers in cellular and infection microbiology · 2020 Alterations of Gut Microbiome in Tibetan Patients With Coronary Heart Disease. Liu F, Fan C, Zhang L, et al. Blautia PubMed ↗
BMC genomics · 2019 Changes of intestinal bacterial microbiota in coronary heart disease complicated with nonalcoholic fatty liver disease. Zhang Y, Xu J, Wang X, et al. Bacteroides fragilisBifidobacterium longumMediterraneibacter gnavusPhocaeicola dorei PubMed ↗
Oxidative medicine and cellular longevity · 2019 Chitosan Oligosaccharides Show Protective Effects in Coronary Heart Disease by Improving Antioxidant Capacity via the Increase in Intestinal Probiotics. Jiang T, Xing X, Zhang L, et al. Faecalibacterium PubMed ↗
The Journal of infectious diseases · 2019 Gut Microbiota in Human Immunodeficiency Virus-Infected Individuals Linked to Coronary Heart Disease. Kehrmann J, Menzel J, Saeedghalati M, et al. Bacteroides PubMed ↗